Foster James Alexander Cunliffe - 31 Dec 2022 SCHEDULE 13G Report for Virax Biolabs Group Limited Ordinary Shares (VRAX)

Filing Manager: Foster James Alexander Cunliffe
Reporting Manager: James Foster
Security: Virax Biolabs Group Limited Ordinary Shares
Symbol: VRAX
Shares outstanding: 1,156,574 shares
Disclosed Ownership: 287,987 shares
Ownership: 25%
Form type: SCHEDULE 13G
Filing time: 29 Oct 2025, 17:09:46 UTC
Date of event: 31 Dec 2022
Next filing: 29 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
James Foster	25%	287,987	287,987	0	James Foster	Chief Executive Officer